Sato S - Search Results

1

Serum levels of monocyte chemotactic protein-3/CCL7 are raised in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis.

Yanaba K, Komura K, Kodera M, Matsushita T, Hasegawa M, Takehara K, Sato S. Yanaba K, et al. Among authors: sato s. Ann Rheum Dis. 2006 Jan;65(1):124-6. doi: 10.1136/ard.2005.040782. Ann Rheum Dis. 2006. PMID: 16344498 Free PMC article.

2

Serum levels of connective tissue growth factor are elevated in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis.

Sato S, Nagaoka T, Hasegawa M, Tamatani T, Nakanishi T, Takigawa M, Takehara K. Sato S, et al. J Rheumatol. 2000 Jan;27(1):149-54. J Rheumatol. 2000. PMID: 10648031

3

Elevated serum KL-6 levels in patients with systemic sclerosis: association with the severity of pulmonary fibrosis.

Sato S, Nagaoka T, Hasegawa M, Nishijima C, Takehara K. Sato S, et al. Dermatology. 2000;200(3):196-201. doi: 10.1159/000018382. Dermatology. 2000. PMID: 10828626

4

Levels of interleukin 12, a cytokine of type 1 helper T cells, are elevated in sera from patients with systemic sclerosis.

Sato S, Hanakawa H, Hasegawa M, Nagaoka T, Hamaguchi Y, Nishijima C, Komatsu K, Hirata A, Takehara K. Sato S, et al. J Rheumatol. 2000 Dec;27(12):2838-42. J Rheumatol. 2000. PMID: 11128673

5

Renal vascular damage in Japanese patients with systemic sclerosis.

Nishijima C, Sato S, Hasegawa M, Nagaoka T, Hirata A, Komatsu K, Takehara K. Nishijima C, et al. Among authors: sato s. Rheumatology (Oxford). 2001 Apr;40(4):406-9. doi: 10.1093/rheumatology/40.4.406. Rheumatology (Oxford). 2001. PMID: 11312378

6

Elevated serum L-selectin levels and decreased L-selectin expression on CD8(+) lymphocytes in systemic sclerosis.

Shimada Y, Hasegawa M, Takehara K, Sato S. Shimada Y, et al. Among authors: sato s. Clin Exp Immunol. 2001 Jun;124(3):474-9. doi: 10.1046/j.1365-2249.2001.01514.x. Clin Exp Immunol. 2001. PMID: 11472411 Free PMC article.

7

Anti-agalactosyl IgG antibodies in sera from patients with systemic sclerosis.

Nishijima C, Sato S, Takehara K. Nishijima C, et al. Among authors: sato s. J Rheumatol. 2001 Aug;28(8):1847-51. J Rheumatol. 2001. PMID: 11508588

8

Serum levels of interleukin-6 and interleukin-10 correlate with total skin thickness score in patients with systemic sclerosis.

Sato S, Hasegawa M, Takehara K. Sato S, et al. J Dermatol Sci. 2001 Oct;27(2):140-6. doi: 10.1016/s0923-1811(01)00128-1. J Dermatol Sci. 2001. PMID: 11532378

9

Clinical significance of anti-topoisomerase I antibody levels determined by ELISA in systemic sclerosis.

Sato S, Hamaguchi Y, Hasegawa M, Takehara K. Sato S, et al. Rheumatology (Oxford). 2001 Oct;40(10):1135-40. doi: 10.1093/rheumatology/40.10.1135. Rheumatology (Oxford). 2001. PMID: 11600743

10

Clinical significance of soluble CD31 in patients with systemic sclerosis (SSc): association with limited cutaneous SSc.

Sato S, Komura K, Hasegawa M, Fujimoto M, Takehara K. Sato S, et al. J Rheumatol. 2001 Nov;28(11):2460-5. J Rheumatol. 2001. PMID: 11708419

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12,243 results

Search Page

Filters